Home Lilly profit beats analyst estimates as Cymbalta sales climb
 

Keywords :   


Lilly profit beats analyst estimates as Cymbalta sales climb

2013-01-29 16:01:20| Biotech - Topix.net

Eli Lilly and Co.'s fourth quarter earnings slipped 4 percent as generic competition continued to eat away at sales of its former best-seller, the antipsychotic Zyprexa, but the drugmaker cut expenses again and growth from other products helped it beat analyst expectations.

Tags: sales profit estimates analyst

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11SCR
28.1146
28.11BOSS OD-2 TURBO Over Drive
28.11/ Pulling the Plug
28.11
28.1110
28.112.5 120
28.11MSV-R
More »